Clinical Trial Update: Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating anlotinib with toripalimab for refractory and advanced soft-tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Anlotinib (anlotinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Sarcoma,Soft Tissue | Phase 2 | Status: UNKNOWN